Answers are grounded in this paper and cite their sources.
The increasing number of treatment options for patients with metastatic carcinomas has created an accompanying need for methods to determine if the tumor will be responsive to the intended therapy and to monitor its effectiveness. Ideally, these methods would be noninvasive and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor cells shed into the blood during metastasis may satisfy this need. Here we review the CellSearch technology used for the detection of circulating tumor cells and discuss potential future directions for improvements.
No takes yet. Share an insight, caveat, or question.
Wit et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: